Related Experiment Video
Updated: May 14, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
BioGranat-IG: a network analysis tool to suggest mechanisms of genetic heterogeneity from exome-sequencing data
Nick Dand1, Frauke Sprengel, Volker Ahlers
1Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK.
Motivation:
Recent exome-sequencing studies have successfully identified disease-causing sequence variants for several rare monogenic diseases by examining variants common to a group of patients. However, the current data analysis strategies are only insufficiently able to deal with confounding factors such as genetic heterogeneity, incomplete penetrance, individuals lacking data and involvement of several genes.
Results:
We introduce BioGranat-IG, an analysis strategy that incorporates the information contained in biological networks to the analysis of exome-sequencing data. To identify genes that may have a disease-causing role, we label all nodes of the network according to the individuals that are carrying a sequence variant and subsequently identify small subnetworks linked to all or most individuals. Using simulated exome-sequencing data, we demonstrate that BioGranat-IG is able to recover the genes responsible for two diseases known to be caused by variants in an underlying complex. We also examine the performance of BioGranat-IG under various conditions likely to be faced by the user, and show that its network-based approach is more powerful than a set-cover-based approach.
Related Concept Videos
Evolutionary Relationships through Genome Comparisons
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
